Monogram Orthopaedics, Inc. (MGRM)
USD 2.71
(-3.9%)
USD 2.71
(-3.9%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 17.63 Million USD | 66.27% |
| 2022 | 10.35 Million USD | -0.86% |
| 2021 | 10.44 Million USD | 52.5% |
| 2020 | 6.85 Million USD | 308.59% |
| 2019 | 1.67 Million USD | 157.9% |
| 2018 | 650.12 Thousand USD | 2.31% |
| 2017 | 635.44 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 3.5 Million USD | -15.29% |
| 2024 Q2 | 3.52 Million USD | 3.69% |
| 2023 Q2 | 5.73 Million USD | 47.28% |
| 2023 Q1 | 3.89 Million USD | 32.38% |
| 2023 FY | 17.22 Million USD | 66.27% |
| 2023 Q4 | 4.13 Million USD | 10.11% |
| 2023 Q3 | 3.75 Million USD | -34.53% |
| 2022 Q2 | 1.82 Million USD | -51.48% |
| 2022 Q1 | 3.77 Million USD | 12.64% |
| 2022 Q3 | 1.81 Million USD | -0.9% |
| 2022 FY | 10.35 Million USD | -0.86% |
| 2022 Q4 | 2.94 Million USD | 62.31% |
| 2021 FY | 10.44 Million USD | 52.5% |
| 2021 Q3 | 3.34 Million USD | 25.97% |
| 2021 Q4 | 3.34 Million USD | 0.0% |
| 2021 Q1 | 2.65 Million USD | 33.97% |
| 2021 Q2 | 2.65 Million USD | -0.0% |
| 2020 Q3 | 1.98 Million USD | -23.38% |
| 2020 FY | 6.85 Million USD | 308.59% |
| 2020 Q4 | 1.98 Million USD | 0.0% |
| 2020 Q2 | 2.58 Million USD | 0.0% |
| 2020 Q1 | 2.58 Million USD | 363.08% |
| 2019 Q2 | 279.25 Thousand USD | 0.0% |
| 2019 Q1 | 279.25 Thousand USD | 58.45% |
| 2019 Q4 | 559.09 Thousand USD | 0.0% |
| 2019 Q3 | 559.09 Thousand USD | 100.21% |
| 2019 FY | 1.67 Million USD | 157.9% |
| 2018 Q4 | 176.23 Thousand USD | 0.0% |
| 2018 FY | 650.12 Thousand USD | 2.31% |
| 2018 Q1 | 148.82 Thousand USD | 0.0% |
| 2018 Q2 | 148.82 Thousand USD | -0.0% |
| 2018 Q3 | 176.23 Thousand USD | 18.42% |
| 2017 FY | 635.44 Thousand USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -57.101% |
| Cerus Corporation | 143.15 Million USD | 87.683% |
| OrthoPediatrics Corp. | 137.01 Million USD | 87.131% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -55.208% |
| Talis Biomedical Corporation | 67.18 Million USD | 73.755% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | 29.315% |
| Inogen, Inc. | 236.08 Million USD | 92.531% |
| Spectral AI, Inc. | 20.86 Million USD | 15.486% |
| Nano-X Imaging Ltd. | 55.99 Million USD | 68.511% |
| CVRx, Inc. | 76.14 Million USD | 76.842% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -399.803% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -41.188% |
| Orthofix Medical Inc. | 667.42 Million USD | 97.358% |
| Venus Concept Inc. | 80.47 Million USD | 78.089% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | 68.834% |
| Bioventus Inc. | 409.91 Million USD | 95.698% |
| BrainsWay Ltd. | 28.01 Million USD | 37.065% |
| Envoy Medical, Inc. | 17.89 Million USD | 1.48% |
| electroCore, Inc. | 32.03 Million USD | 44.95% |
| IceCure Medical Ltd | 16.87 Million USD | -4.486% |
| Lucid Diagnostics Inc. | 42.43 Million USD | 58.444% |
| MaxCyte, Inc. | 84.84 Million USD | 79.217% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -42.067% |
| Nexalin Technology, Inc. | 5.78 Million USD | -204.998% |
| PAVmed Inc | 64.82 Million USD | 72.8% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | 65.478% |
| RxSight, Inc. | 103.85 Million USD | 83.021% |
| Sight Sciences, Inc. | 126.44 Million USD | 86.055% |
| SI-BONE, Inc. | 156.35 Million USD | 88.722% |
| TELA Bio, Inc. | 84.18 Million USD | 79.055% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 74.83% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 91.329% |
| LivaNova PLC | 843.54 Million USD | 97.91% |
| 908 Devices Inc. | 68.08 Million USD | 74.1% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 96.354% |
| Nemaura Medical Inc. | 7.13 Million USD | -147.003% |
| NeuroPace, Inc. | 75.29 Million USD | 76.582% |
| LENSAR, Inc. | 33.33 Million USD | 47.105% |
| Apyx Medical Corporation | 51.01 Million USD | 65.438% |
| Cutera, Inc. | 197.72 Million USD | 91.082% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | 28.845% |
| BioSig Technologies, Inc. | 28.53 Million USD | 38.195% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 90.791% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | 51.101% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 97.892% |
| Axonics, Inc. | 270.2 Million USD | 93.474% |
| Outset Medical, Inc. | 198.77 Million USD | 91.129% |
| IRIDEX Corporation | 31.81 Million USD | 44.575% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 90.216% |
| IRadimed Corporation | 30.12 Million USD | 41.463% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -106.669% |
| INVO Bioscience, Inc. | 7.85 Million USD | -124.53% |
| Telesis Bio, Inc. | 63.48 Million USD | 72.227% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 82.09% |
| Varex Imaging Corporation | 224.8 Million USD | 92.156% |
| Quipt Home Medical Corp. | 148.66 Million USD | 88.139% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -50.414% |
| Pulmonx Corporation | 112.68 Million USD | 84.352% |
| Dynatronics Corporation | 9.9 Million USD | -77.967% |
| Modular Medical, Inc. | 17.52 Million USD | -0.593% |
| ReShape Lifesciences Inc. | 20.18 Million USD | 12.652% |
| Semler Scientific, Inc. | 38.94 Million USD | 54.722% |
| InMode Ltd. | 215.68 Million USD | 91.824% |
| Bruker Corporation | 1.07 Billion USD | 98.362% |
| Cytosorbents Corporation | 48.33 Million USD | 63.521% |
| DexCom, Inc. | 1.69 Billion USD | 98.957% |
| Align Technology, Inc. | 2.07 Billion USD | 99.151% |
| Viveve Medical, Inc. | 22.17 Million USD | 20.475% |
| ZimVie Inc. | 275.12 Million USD | 93.591% |
| Movano Inc. | 29.69 Million USD | 40.61% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 87.155% |
| Nexalin Technology, Inc. | 5.78 Million USD | -204.998% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -399.803% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 97.066% |
| Profound Medical Corp. | 33.6 Million USD | 47.526% |
| Insulet Corporation | 939.9 Million USD | 98.124% |
| enVVeno Medical Corporation | 25.23 Million USD | 30.133% |
| Surmodics, Inc. | 98.69 Million USD | 82.134% |
| iCAD, Inc. | 22.22 Million USD | 20.661% |
| Nuwellis, Inc. | 22.61 Million USD | 22.023% |
| Biotricity, Inc. | 17.18 Million USD | -2.61% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 96.045% |
| Aethlon Medical, Inc. | 12.27 Million USD | -43.621% |
| InspireMD, Inc. | 22.95 Million USD | 23.168% |
| PAVmed Inc. | 64.82 Million USD | 72.8% |
| BIOLASE, Inc. | 34.66 Million USD | 49.127% |
| Beyond Air, Inc. | 61.7 Million USD | 71.421% |
| FONAR Corporation | 28.6 Million USD | 38.356% |
| AxoGen, Inc. | 149.33 Million USD | 88.192% |
| Vivani Medical, Inc. | 26.96 Million USD | 34.608% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 90.043% |
| Inari Medical, Inc. | 448.59 Million USD | 96.069% |
| UFP Technologies, Inc. | 58.08 Million USD | 69.645% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -257.842% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -179.079% |
| Tenon Medical, Inc. | 16.96 Million USD | -3.919% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -138.51% |
| Co-Diagnostics, Inc. | 44.1 Million USD | 60.018% |
| AdaptHealth Corp. | 1.07 Billion USD | 98.364% |
| Sintx Technologies, Inc. | 15.2 Million USD | -15.999% |
| NanoVibronix, Inc. | 4.97 Million USD | -254.575% |
| Quanterix Corporation | 118.1 Million USD | 85.069% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -50.414% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -22.095% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 95.509% |
| TransMedics Group, Inc. | 182.82 Million USD | 90.355% |
| ReWalk Robotics Ltd. | 28.06 Million USD | 37.171% |
| NeuroMetrix, Inc. | 11.09 Million USD | -58.871% |
| Hyperfine, Inc. | 52.87 Million USD | 66.65% |
| Establishment Labs Holdings Inc. | 172 Million USD | 89.748% |
| Biomerica, Inc. | 6.97 Million USD | -152.695% |
| Bone Biologics Corporation | 9.42 Million USD | -87.022% |
| AVITA Medical, Inc. | 80.77 Million USD | 78.171% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -71.008% |
| Silk Road Medical, Inc | 186.35 Million USD | 90.538% |